Wende Li1, Peigen Huang2, David J Chen3, Leo E Gerweck4. 1. Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA; Guangdong Medical College, PR China. 2. Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA. 3. Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, USA. 4. Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA. Electronic address: LGerweck@mgh.harvard.edu.
Abstract
BACKGROUND AND PURPOSE: The causes of tumor response variation to radiation remain obscure, thus hampering the development of predictive assays and strategies to decrease resistance. The present study evaluates the impact of host tumor stromal elements and the in vivo environment on tumor cell kill, and relationship between tumor cell radiosensitivity and the tumor control dose. MATERIAL AND METHODS: Five endpoints were evaluated and compared in a radiosensitive DNA double-strand break repair-defective (DNA-PKcs(-/-)) tumor line, and its DNA-PKcs repair competent transfected counterpart. In vitro colony formation assays were performed on in vitro cultured cells, on cells obtained directly from tumors, and on cells irradiated in situ. Permanent local control was assessed by the TCD50 assay. Vascular effects were evaluated by functional vascular density assays. RESULTS: The fraction of repair competent and repair deficient tumor cells surviving radiation did not substantially differ whether irradiated in vitro, i.e., in the absence of host stromal elements and factors, from the fraction of cells killed following in vivo irradiation. Additionally, the altered tumor cell sensitivity resulted in a proportional change in the dose required to achieve permanent local control. The estimated number of tumor cells per tumor, their cloning efficiency and radiosensitivity, all assessed by in vitro assays, were used to predict successfully, the measured tumor control doses. CONCLUSION: The number of clonogens per tumor and their radiosensitivity govern the permanent local control dose. Published by Elsevier Ireland Ltd.
BACKGROUND AND PURPOSE: The causes of tumor response variation to radiation remain obscure, thus hampering the development of predictive assays and strategies to decrease resistance. The present study evaluates the impact of host tumor stromal elements and the in vivo environment on tumor cell kill, and relationship between tumor cell radiosensitivity and the tumor control dose. MATERIAL AND METHODS: Five endpoints were evaluated and compared in a radiosensitive DNA double-strand break repair-defective (DNA-PKcs(-/-)) tumor line, and its DNA-PKcs repair competent transfected counterpart. In vitro colony formation assays were performed on in vitro cultured cells, on cells obtained directly from tumors, and on cells irradiated in situ. Permanent local control was assessed by the TCD50 assay. Vascular effects were evaluated by functional vascular density assays. RESULTS: The fraction of repair competent and repair deficient tumor cells surviving radiation did not substantially differ whether irradiated in vitro, i.e., in the absence of host stromal elements and factors, from the fraction of cells killed following in vivo irradiation. Additionally, the altered tumor cell sensitivity resulted in a proportional change in the dose required to achieve permanent local control. The estimated number of tumor cells per tumor, their cloning efficiency and radiosensitivity, all assessed by in vitro assays, were used to predict successfully, the measured tumor control doses. CONCLUSION: The number of clonogens per tumor and their radiosensitivity govern the permanent local control dose. Published by Elsevier Ireland Ltd.
Authors: Mónica García-Barros; Tin Htwe Thin; Jerzy Maj; Carlos Cordon-Cardo; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick Journal: Cancer Res Date: 2010-10-05 Impact factor: 12.701
Authors: Leo E Gerweck; Shashirekha Vijayappa; Akihiro Kurimasa; Kazuhiko Ogawa; David J Chen Journal: Cancer Res Date: 2006-09-01 Impact factor: 12.701
Authors: H Hashizume; P Baluk; S Morikawa; J W McLean; G Thurston; S Roberge; R K Jain; D M McDonald Journal: Am J Pathol Date: 2000-04 Impact factor: 4.307
Authors: Kazuhiko Ogawa; Yves Boucher; Satoshi Kashiwagi; Dai Fukumura; David Chen; Leo E Gerweck Journal: Cancer Res Date: 2007-05-01 Impact factor: 12.701
Authors: Ala Yaromina; Marie Krause; Howard Thames; Andrea Rosner; Mechthild Krause; Franziska Hessel; Reidar Grenman; Daniel Zips; Michael Baumann Journal: Radiother Oncol Date: 2007-05-22 Impact factor: 6.280
Authors: Yu-Fen Lin; Benjamin P Chen; Wende Li; Zoltan Perko; Yi Wang; Mauro Testa; Robert Schneider; Hsaio-Ming Lu; Leo E Gerweck Journal: Int J Part Ther Date: 2018-03-21